Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Next Generation Vaccine Biomarkers workshop October 30-31, 2014--Ottawa, Canada.

Twine SM, Fulton KM, Spika J, Ouellette M, Raven JF, Conlan JW, Krishnan L, Barreto L, Richards JC.

Hum Vaccin Immunother. 2015;11(12):2923-30. doi: 10.1080/21645515.2015.1083663.

3.

Francisella tularensis: a red-blooded pathogen.

Conlan JW.

J Infect Dis. 2011 Jul 1;204(1):6-8. doi: 10.1093/infdis/jir224. No abstract available.

4.

Tularemia vaccines: recent developments and remaining hurdles.

Conlan JW.

Future Microbiol. 2011 Apr;6(4):391-405. doi: 10.2217/fmb.11.22. Review.

PMID:
21526941
5.

Infection of mice with Francisella as an immunological model.

Conlan JW, Chen W, Bosio CM, Cowley SC, Elkins KL.

Curr Protoc Immunol. 2011 Apr;Chapter 19:Unit 19.14. doi: 10.1002/0471142735.im1914s93.

6.

Measurement of macrophage-mediated killing of intracellular bacteria, including Francisella and mycobacteria.

Elkins KL, Cowley SC, Conlan JW.

Curr Protoc Immunol. 2011 Apr;Chapter 14:Unit14.25. doi: 10.1002/0471142735.im1425s93.

PMID:
21462167
7.

Role of neutrophils and NADPH phagocyte oxidase in host defense against respiratory infection with virulent Francisella tularensis in mice.

KuoLee R, Harris G, Conlan JW, Chen W.

Microbes Infect. 2011 May;13(5):447-56. doi: 10.1016/j.micinf.2011.01.010. Epub 2011 Jan 26.

PMID:
21277990
8.

Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Twine SM, Petit MD, Fulton KM, House RV, Conlan JW.

PLoS One. 2010 Apr 2;5(4):e10000. doi: 10.1371/journal.pone.0010000.

9.

Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.

Conlan JW, Shen H, Golovliov I, Zingmark C, Oyston PC, Chen W, House RV, Sjöstedt A.

Vaccine. 2010 Feb 17;28(7):1824-31. doi: 10.1016/j.vaccine.2009.12.001. Epub 2009 Dec 16.

10.

Differential susceptibility of Sprague-Dawley and Fischer 344 rats to infection by Francisella tularensis.

Raymond CR, Conlan JW.

Microb Pathog. 2009 Apr;46(4):231-4. doi: 10.1016/j.micpath.2009.01.002. Epub 2009 Feb 7.

PMID:
19490832
11.

Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.

Sebastian S, Pinkham JT, Lynch JG, Ross RA, Reinap B, Blalock LT, Conlan JW, Kasper DL.

Vaccine. 2009 Jan 22;27(4):597-605. doi: 10.1016/j.vaccine.2008.10.079. Epub 2008 Nov 18.

12.

Lymphotoxin-alpha plays only a minor role in host resistance to respiratory infection with virulent type A Francisella tularensis in mice.

Zhang D, Kuolee R, Harris G, Zhang Q, Conlan JW, Chen W.

Mediators Inflamm. 2008;2008:239740. doi: 10.1155/2008/239740.

13.

Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis.

Conlan JW, Zhao X, Harris G, Shen H, Bolanowski M, Rietz C, Sjostedt A, Chen W.

Mol Immunol. 2008 May;45(10):2962-9. doi: 10.1016/j.molimm.2008.01.022. Epub 2008 Mar 5.

14.

Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.

van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W.

Infect Immun. 2007 Dec;75(12):5597-608. Epub 2007 Oct 1.

16.

A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.

Sebastian S, Dillon ST, Lynch JG, Blalock LT, Balon E, Lee KT, Comstock LE, Conlan JW, Rubin EJ, Tzianabos AO, Kasper DL.

Infect Immun. 2007 May;75(5):2591-602. Epub 2007 Feb 12.

17.

Mouse model of oral infection with virulent type A Francisella tularensis.

KuoLee R, Zhao X, Austin J, Harris G, Conlan JW, Chen W.

Infect Immun. 2007 Apr;75(4):1651-60. Epub 2007 Jan 22.

18.

Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines.

Twine SM, Petit MD, Shen H, Mykytczuk NC, Kelly JF, Conlan JW.

Biochem Biophys Res Commun. 2006 Aug 4;346(3):999-1008. Epub 2006 Jun 9. Erratum in: Biochem Biophys Res Commun. 2006 Sep 8;347(4):1171.

PMID:
16781667
19.

Virulence comparison in mice of distinct isolates of type A Francisella tularensis.

Twine SM, Shen H, Kelly JF, Chen W, Sjöstedt A, Conlan JW.

Microb Pathog. 2006 Mar;40(3):133-8. Epub 2006 Jan 31.

20.

Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion.

Chen W, Kuolee R, Austin JW, Shen H, Che Y, Conlan JW.

Microb Pathog. 2005 Nov-Dec;39(5-6):189-96. Epub 2005 Oct 28.

21.

Francisella tularensis proteome: low levels of ASB-14 facilitate the visualization of membrane proteins in total protein extracts.

Twine SM, Mykytczuk NC, Petit M, Tremblay TL, Lanthier P, Conlan JW, Kelly JF.

J Proteome Res. 2005 Sep-Oct;4(5):1848-54. Erratum in: J Proteome Res. 2006 Jun;5(6):1504. Lanthier, P [added].

PMID:
16212441
22.

Identification of a D-glycero-D-manno-heptosyltransferase gene from Helicobacter pylori.

Hiratsuka K, Logan SM, Conlan JW, Chandan V, Aubry A, Smirnova N, Ulrichsen H, Chan KH, Griffith DW, Harrison BA, Li J, Altman E.

J Bacteriol. 2005 Aug;187(15):5156-65.

23.

Toll-like receptor 4 (TLR4) plays a relatively minor role in murine defense against primary intradermal infection with Francisella tularensis LVS.

Chen W, Kuolee R, Shen H, Bùsa M, Conlan JW.

Immunol Lett. 2005 Feb 15;97(1):151-4. No abstract available.

PMID:
15626487
24.
26.

Vaccines against Francisella tularensis--past, present and future.

Conlan JW.

Expert Rev Vaccines. 2004 Jun;3(3):307-14. Review.

PMID:
15176947
28.
29.

Ability of Escherichia coli O157:H7 isolates to colonize the intestinal tract of conventional adult CD1 mice is transient.

Conlan JW, Bardy SL, KuoLee R, Webb A, Perry MB.

Can J Microbiol. 2001 Jan;47(1):91-5.

PMID:
15049456
31.
33.

Structural analysis of Francisella tularensis lipopolysaccharide.

Vinogradov E, Perry MB, Conlan JW.

Eur J Biochem. 2002 Dec;269(24):6112-8.

36.

Helicobacter pylori from asymptomatic hosts expressing heptoglycan but lacking Lewis O-chains: Lewis blood-group O-chains may play a role in Helicobacter pylori induced pathology.

Monteiro MA, St Michael F, Rasko DA, Taylor DE, Conlan JW, Chan KH, Logan SM, Appelmelk BJ, Perry MB.

Biochem Cell Biol. 2001;79(4):449-59.

PMID:
11527214
40.
41.
42.
43.
46.

Immunity to Listeria monocytogenes.

North RJ, Conlan JW.

Chem Immunol. 1998;70:1-20. Review. No abstract available.

PMID:
9509668
47.

Murine listeriosis as a model of antimicrobial defense.

North RJ, Dunn PL, Conlan JW.

Immunol Rev. 1997 Aug;158:27-36. Review.

PMID:
9314071

Supplemental Content

Loading ...
Support Center